Japan Asia Investment

AMP offers financial advisory services such as M&A brokerage, overseas expansion, and business expansion based on the needs of the client.

KIC Holdings operates in the asset management and real estate sectors, focusing primarily on investment and advisory services. The company specializes in the management of distribution centers, warehouses, and trunk rooms, providing comprehensive support that includes due diligence, acquisition, financing, and management planning. KIC Holdings aims to facilitate real estate investment management both in Japan and internationally, offering clients tailored financial products and services to enhance their asset management capabilities.

Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, producing high-performance measurement systems that utilize multi-path scattered field theory. Integral Geometry Science is particularly noted for its microwave mammography system, which addresses challenges in imaging high-density breast tissue. This innovative technology improves the clarity of images, allowing for accurate differentiation between cancerous and normal tissue, thus reducing the need for painful and radiation-exposing conventional screening methods. Additionally, the company manufactures nondestructive inspection systems for lithium-ion batteries, contributing to safety and reliability in battery technology.

Croco Corporation, founded in 2015 and based in Tokyo, Japan, specializes in web marketing and content solutions aimed at supporting global business ventures. The company offers a comprehensive range of services including content marketing implementation, which encompasses current situation analysis, policy formulation, production, editing, proofreading, and effect measurement. Utilizing natural language processing technology, Croco identifies user search needs and extracts relevant keywords to create informative article content. This approach enables enterprises to develop effective growth strategies and enhance their marketing operations. Additionally, Croco provides crowd sourcing and plagiarism check services, further solidifying its role in the digital marketing landscape.

Last One Mile Co Ltd specializes in facilitating connections between telecommunications facilities and customers. The company offers a comprehensive range of services, including the sale of new electronic power, gas, and internet connections. By providing essential infrastructure, Last One Mile aims to enhance connectivity and access to utilities for its clientele, ensuring efficient service delivery in a rapidly evolving technological landscape.

YAMAP is an internet company that focuses on developing web and mobile applications tailored for mountain climbing and outdoor activities. Its flagship application enables users to determine their location using GPS signals from satellites, which is particularly useful in areas without mobile phone service coverage. In addition to location services, YAMAP provides a variety of trekking products and resources, enhancing the experience for trekkers and outdoor enthusiasts by offering access to essential tools and information related to their activities.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

Nippon Souken Ltd., founded in 1996 and located in Takamatsu, Japan, provides insurance brokerage services and specializes in risk management. The company focuses on delivering tailored financial solutions to meet the needs of its clients in the insurance sector.

FacePeer, Inc., founded in 2015 and based in Tokyo, Japan, specializes in developing a Web-based face-to-face communications platform known as FaceHub. The company offers two main services: FaceHub, a video call platform tailored for businesses, and ViewHub, a web interview service designed specifically for job interviews. By providing solutions that cater to various operating systems and specific business challenges, FacePeer aims to enhance operational efficiency and transform workplace practices. The company focuses on facilitating effective online communication, allowing businesses to support sustainable growth while fostering a connected society where individuals can thrive.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Laxus Technologies operates an online fashion-sharing platform that specializes in the rental of designer handbags. The platform enables users to borrow high-end handbags for an unlimited duration, with the option for free replacements. This service allows women to access luxury fashion items in a cost-effective manner, catering to individual preferences and budgets. Through its application, Laxus Technologies facilitates seamless transactions, allowing consumers to acquire goods directly from sellers via a web browser or mobile app.

J-ARM is a medical laboratory focused on advancing cell therapy and regenerative medicine for pets, specifically dogs and cats. The company develops immune cell culture kits and offers a variety of biotechnological services aimed at supporting the treatment of pet illnesses. J-ARM provides consultation sessions related to cultured cells and safety tests, ensuring that animal hospitals and pet owners have access to innovative medical solutions. With a portfolio that includes over ten types of cell culture kits, J-ARM enables the implementation of advanced treatments in veterinary care.

Wonderplanet Inc. is a company based in Nagoya, Japan, that specializes in designing and developing native language applications and games for smartphones and tablets. Founded in 2012, Wonderplanet offers a range of both 2D and 3D games compatible with iOS and Android platforms. The company focuses on creating engaging content that caters to diverse language needs, enhancing the user experience in mobile gaming and applications.

Ligua Inc. is a consultancy firm based in Osaka, Japan, specializing in management support services for the healthcare industry. Established in 2004, the company offers a range of consulting services focused on enhancing sales office operations, including sales improvement, organizational management, executive education, and recruitment. Additionally, Ligua provides corporate management support, which encompasses the management of key performance indicators and the development of business plans. The firm also delivers problem-solving tools tailored for osteopaths, along with services related to insurance, financial products brokerage, and medical expenses billing. Ligua aims to contribute to a healthy and fulfilling life for individuals, supporting businesses in the financial, health, and wellness sectors.

TORICO operates an online platform and application that specializes in the sale of books and e-books. Founded in 2005 and based in Chisoda, Timis, the company is also involved in the operation of Comic EC MANGAZENKAN.COM. In addition to its core book-selling activities, TORICO focuses on the planning, development, marketing, and sales of manga and Japanese animation goods, as well as various manga-based services.

Wonderleague is a manufacturer of VR and AR goggles and controllers intended to provide the best quality products and experiences.The company leverages technology to build AR and VR headsets and controllers available on ios and android devices and also develop an AR platform, enabling customers to have an interactive experience.

FacePeer, Inc., founded in 2015 and based in Tokyo, Japan, specializes in developing a Web-based face-to-face communications platform known as FaceHub. The company offers two main services: FaceHub, a video call platform tailored for businesses, and ViewHub, a web interview service designed specifically for job interviews. By providing solutions that cater to various operating systems and specific business challenges, FacePeer aims to enhance operational efficiency and transform workplace practices. The company focuses on facilitating effective online communication, allowing businesses to support sustainable growth while fostering a connected society where individuals can thrive.

FunPep is a biotechnology company dedicated to the research and development of pharmaceuticals, cosmetics, and medical devices centered on functional peptides. The company specializes in creating treatments for intractable peptic ulcer disease, including antibody drugs and other pharmaceutical products. FunPep aims to innovate within the pharmaceutical sector by replacing traditional antibody medicines with next-generation products that utilize antibody-inducing peptides. Through its diverse portfolio, FunPep seeks to advance healthcare solutions and improve patient outcomes.

Aoi Co. is a Tokyo-based company that provides "Aoi Zemi," a free online lecture service designed for junior high and middle school students. The platform has successfully attracted over 3,000 users and boasts an impressive entrance exam passing rate of 86.3% for students aiming for their preferred universities. Aoi Co. is focused on enhancing its system development capabilities and plans to launch a learning state monitoring app for parents in September.

Eltes Co Ltd is a company based in Japan that specializes in big data analysis with a focus on risk detection. It offers consultation services that leverage digital risk technology to protect large databases and storage systems. Eltes provides internal fraud detection services aimed at preventing information security breaches caused by internal factors, as well as solutions for detecting and diagnosing security breaches stemming from external threats. Through its innovative approach to risk management, Eltes addresses critical security challenges for organizations by ensuring the integrity and safety of their data.

FunPep is a biotechnology company dedicated to the research and development of pharmaceuticals, cosmetics, and medical devices centered on functional peptides. The company specializes in creating treatments for intractable peptic ulcer disease, including antibody drugs and other pharmaceutical products. FunPep aims to innovate within the pharmaceutical sector by replacing traditional antibody medicines with next-generation products that utilize antibody-inducing peptides. Through its diverse portfolio, FunPep seeks to advance healthcare solutions and improve patient outcomes.

TMS is a Tokyo-based clinical-stage biotech company that unlocks fungus-derived SMTP small molecule compound group. SMTPs have novel dual mode of action, both thrombolytic and anti-inflammatory. The lead compound TMS-007 is in Phase IIa clinical trial indicated for acute ischemic stroke and partnered with Biogen.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

JMC manufactures and sells prototypes, parts, and products using 3D printers, sand casting for industrial CT, and inspection and measurement services. They also provide 3D printer output, a CT biology encyclopedia, and 3DiH printer services.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

TMS is a Tokyo-based clinical-stage biotech company that unlocks fungus-derived SMTP small molecule compound group. SMTPs have novel dual mode of action, both thrombolytic and anti-inflammatory. The lead compound TMS-007 is in Phase IIa clinical trial indicated for acute ischemic stroke and partnered with Biogen.

Rich Media offers media portal, web creation, and search engine optimization services.

BioAmber is a private company based in Delaware that specializes in the production of renewable succinic acid and related chemical intermediates. Formerly known as DNP Green Technology, the company rebranded following its acquisition of a joint venture with ARD. Utilizing a proprietary technology platform that integrates industrial biotechnology and chemical catalysis, BioAmber converts bio-based feedstocks into a variety of renewable chemicals. Its product offerings include materials for polyurethanes, resins, coatings, de-icing solutions, fine chemicals, lubricants, and engineering plastics, among others. The company aims to provide sustainable industrial chemical solutions to its clients, contributing to a more eco-friendly chemical industry.

Zibolan is a digital marketing company provides internet marketing and search engine optimisation.

Analogix Semiconductor, Inc. specializes in designing and manufacturing high-performance analog and mixed-signal semiconductor devices tailored for the digital multimedia and communications markets. The company offers a range of products including SlimPort devices, timing controllers, mobile display converters, accessory display converter chips, and display controllers. These products enhance the capabilities of portable devices such as smartphones, tablets, laptops, and televisions, enabling them to deliver high-quality video, audio, and data to high-definition displays. Notably, the SlimPort ANX7688 allows for impressive video resolutions, supporting 4K video at 60 frames per second and full HD at 120 frames per second. Established in 2002, Analogix is headquartered in Santa Clara, California, with additional offices in Beijing and Shenzhen, China, as well as locations in Taiwan, South Korea, and Japan.

Chiral Quest specializes in the development and supply of intermediates essential for the production of innovative pharmaceuticals. The company is particularly focused on the creation and manufacture of chiral catalysts, which play a crucial role in the synthesis of various drugs. With a team of experienced chemists, Chiral Quest excels in transforming lab-scale processes into practical, scalable solutions that enable cost-effective manufacturing. This expertise positions the company as a valuable partner in the global generic drug industry, offering high-quality intermediates to meet the growing demands of pharmaceutical development.

Palo Alto Networks is a California-based cybersecurity company that provides a comprehensive range of security solutions for organizations. The firm specializes in network security, cloud security, and security operations, making it a platform-based vendor in the cybersecurity space. With over 80,000 enterprise customers globally, Palo Alto Networks serves a significant portion of the Global 2000, demonstrating its prominent position in the industry. The company's offerings are designed to protect organizations from evolving cyber threats, ensuring robust security across various digital environments.

Sales Robotics Co., Ltd., founded in 2004 and based in Tokyo, Japan, specializes in developing and providing cloud-based business support services. The company's offerings include building customer databases and sales pipelines, sales strategy consulting, and inside sales support. Additionally, Sales Robotics engages in the sale of salesforce licenses and the construction of sales support systems. The company also focuses on web system development projects and offers a platform tailored for digital content in foreign language education, which includes language lessons alongside marketing and sales solutions. Through these services, Sales Robotics enables businesses to analyze data effectively and refine their sales strategies.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Chestnut Medical Technologies, Inc. specializes in the development of innovative minimally invasive therapies for Interventional Neuroradiology. The company's mission focuses on creating technologies that enhance usability while improving patient outcomes and minimizing complications associated with neurovascular diseases. One of its key products is the Alligator Retrieval Device, designed for the effective retrieval and removal of foreign bodies from both peripheral and intracranial circulation. Through its advancements, Chestnut Medical aims to contribute significantly to the field of neurovascular treatment.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Ecrio, Inc. specializes in providing 4G LTE real-time communications client software and services for the mobile industry. The company's flagship offering, the Ecrio Mobile Communications Client Suite (MCCS), facilitates the deployment of core 4G/LTE services, encompassing voice, video, SMS, and rich communication services (RCS) like video telephony and content sharing. The MCCS includes a variety of products such as the SIP/IMS Framework and Voice over LTE (VoLTE) Framework, which support the development of LTE and IMS-based applications while ensuring interoperability with network infrastructures. Ecrio also offers a Device-Platform SDK for operators and device manufacturers to optimize installations, along with an Application Development SDK for creating communication-rich applications. The company serves a global clientele, including handset manufacturers, mobile service operators, and infrastructure providers, enabling them to enhance customer experiences and streamline the integration of complex communication capabilities. Founded in 1998 and headquartered in Cupertino, California, Ecrio is committed to driving digital transformation in the mobile sector.

Moshimo Co., Ltd. is a Tokyo-based company that specializes in planning and producing internet shopping sites, enabling small businesses to sell merchandise online with ease. Founded in 2006, Moshimo offers a dropshipping service that simplifies supply chain management by allowing wholesale suppliers to hold and ship products, thereby relieving small businesses of the challenges associated with inventory management and order fulfillment. The company provides access to over 350,000 products from more than 800 suppliers, allowing users to create online storefronts efficiently. Moshimo's services are designed to streamline the process of online sales, making it easier for small enterprises to enter the e-commerce market.

A privately held technology company headquartered in London.

Tudou is a Chinese video sharing website launched in 2005 by Wang Tei, designed to empower young users to express their creativity through video content. The platform allows users to watch, upload, rate, share, comment on, and recommend a variety of videos, including user-generated content, licensed material, and original programming. In 2012, Tudou merged with Youku, creating a dominant player in the online video market under the name Youku Tudou, Inc. This merger significantly enhanced the user base, with monthly unique visitors increasing from approximately 182 million in late 2010 to about 227 million by mid-2013, outpacing competitors like Sohu, PPTV, and iQiyi. Tudou's focus on engaging and interactive experiences has made it a key platform for independent video producers in China.

All Ads is a Tokyo-based company that specializes in digital marketing services aimed at enhancing the cost-effectiveness of advertising for business professionals. By focusing on LTV marketing, All Ads combines data, technology, and consulting to optimize advertising strategies. The company provides a range of services including in-house media management, affiliate advertising consulting, operational advertising consulting, and roundtable discussions. Through its comprehensive approach, All Ads seeks to support the growth of its clients' businesses by improving their advertising performance.

B.Creation offers digital services and development of smartphone application useful for fishing and outdoors. The company was established on March 29, 2004.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

BlogBus is a pioneering blog hosting service provider based in China, recognized as the first commercial entity to offer paid blogging services in the Chinese blogosphere. The company focuses on internet community services, catering to the growing demand for personal and professional blogging platforms. By establishing a reputation for quality and reliability, BlogBus has positioned itself as a key player in the Chinese blogging industry, facilitating users in creating and managing their online content effectively.

Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Tixa Internet Technology Co., Ltd., based in Beijing, specializes in web-empowered products, systems, and services, primarily focusing on contextual advertising solutions for online advertisers and publishers in China. The company offers several key products, including NarrowAD, a targeted online advertising solution, and ChinaWi, an online corporate intelligence portal. Tixa also provides PRnews, a platform for delivering press releases to various stakeholders, including media and potential clients. In addition to news distribution, Tixa offers media monitoring services, press release writing and translation, and crisis management services. Its multi-channel delivery network ensures real-time access to a broad audience, encompassing newspapers, wire services, and online databases. Tixa has established strategic partnerships with notable organizations such as Factiva, Bloomberg, and Reuters. Originally founded in 2000 as VeryE, the company rebranded to Tixa Internet Technology in March 2004 following a restructuring supported by Mitsui Sumitomo Financial Group.

Azteq Mobile manufactures and markets mobile devices, palm tops, communication equipment, and handheld devices. The company is based in Walnut Creek, California.

SymBio Pharmaceuticals Limited is a biopharmaceutical company based in Tokyo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs, primarily in the fields of oncology and hematology. The company develops various anti-cancer agents, including Treakisym, which is used to treat non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia, and is currently undergoing Phase III trials for relapsed/refractory diffuse large B-cell lymphoma. Additionally, SymBio is working on several other drug formulations, including SyB L-1701, SyB L-1702, and Rigosertib SyB-C-0501, as well as SyB L-1101 and SyB C-1101 for higher-risk myelodysplastic syndromes. The company also has a candidate, SyB V-1901, aimed at treating infectious diseases. SymBio Pharmaceuticals operates primarily in Japan, South Korea, China, Hong Kong, Taiwan, and Singapore.

CROOZ, Inc. is a Japanese company specializing in mobile social games and e-commerce applications. As a leading provider of smartphone games, it develops and publishes original titles for popular platforms like Mobage, with some games generating significant revenue. In addition to its gaming offerings, CROOZ operates several e-commerce platforms, including SHOPLIST.com, which features a diverse range of fast fashion brands, and SHOPLIST USED, an application that facilitates the buying and selling of used fashion items. The company also runs CROOZblog, a platform for user-generated content. With a focus on both domestic and international markets, CROOZ aims to capitalize on the rapid growth of the global smartphone game industry while expanding its footprint in the e-commerce sector.

InPhase Technologies is a storage company focused on holographic data storage technology.

SMS is a Japanese company focused on providing information services tailored to the needs of an aging society. The company operates in multiple sectors, including nursing care, medical care, career development, healthcare, senior living, and international services. By catering to both business operators and end users, SMS aims to enhance the information infrastructure necessary for supporting the elderly and those involved in their care. Through its diverse offerings, SMS addresses the unique challenges and requirements of an aging population, facilitating access to essential services and information.

Magink Display Technologies Ltd. is a company that specializes in digital display technologies, focusing on providing touch screen solutions primarily for the casino sector. Founded in 2000 and headquartered in Mevasseret Zion, Israel, with additional offices in the United Kingdom and San Francisco, the company’s products are utilized in gaming machines across the United States and Australia. Magink addresses the Out-of-Home media market, offering applications for outdoor advertising, retail signage, public information, and promotional displays. The company is dedicated to the ongoing development of its proprietary technology, which features full-color, high-resolution digital ink display systems known for their low energy consumption and cost-effectiveness. This technology is being tested and deployed in various global markets, enhancing digital display applications across diverse industries.

Beat Holdings Limited is a multi-disciplinary company based in Central, Hong Kong, that specializes in developing applications and services utilizing blockchain technology. The company offers a range of products and services, including software solutions for mobile operators and enterprises, mobile messaging services, and customized mobile applications. It also manages an information website focused on crypto-assets and is involved in licensing intellectual property. Additionally, Beat Holdings has expanded into wellness services, healthcare, and wearable technology, which includes sensors and data analysis. Founded in 1999 and formerly known as Xinhua Holdings Limited, the company operates across China and other Asian markets, including Japan, aiming to facilitate business and investment opportunities while leveraging its expertise and global network.

istyle, Inc. is a company focused on the beauty industry, primarily known for its operation of the cosmetics portal website @cosme. The company manages various segments, including Media, Electronic Commerce, and Store. The Media segment provides a range of services, such as internet advertising, branding, and affiliate marketing. Through its Electronic Commerce segment, istyle engages in the buying and selling of cosmetics, quasi-drugs, and health foods via its online shopping platform. The Store segment is involved in planning and developing cosmetics retail categories, along with operating physical retail stores. Additionally, istyle has expanded its presence internationally, with subsidiaries in countries including Taiwan, China, Hong Kong, Malaysia, Singapore, Thailand, and the United States. The company also offers beauty-related services, including advertising, marketing, and research, as well as personnel dispatching and investment training services.

Rinat Neuroscience, founded in 2001 following a spin-out from Genentech, focuses on developing protein-based therapeutics for various neurological diseases and disorders. The company leverages significant research and development resources previously invested by Genentech to advance its pioneering efforts in antibody drug development. Rinat is dedicated to creating innovative treatments for conditions such as pain, Alzheimer's disease, obesity, diabetes, and neuropathies. Additionally, it is engaged in developing novel therapies aimed at modifying disease progression by targeting and protecting specific populations of neurons affected by these diseases. Through its work, Rinat Neuroscience seeks to improve patient outcomes in the field of neurology.

Triage Medical Inc., an Irvine, Calif.-based developer orthopedic trauma devices.

Sosei Group Corporation is an international biopharmaceutical company based in Japan that focuses on discovering and developing innovative therapies for various medical conditions, including Alzheimer's disease, schizophrenia, cancer, migraine, addiction, and metabolic diseases. The company leverages advanced platform technologies, such as GPCR structure-based drug design, peptide platforms, and nanotechnology, to create a diverse product pipeline with significant therapeutic potential. Sosei Group has successfully partnered in the development and commercialization of three medicines, including two treatments for chronic obstructive pulmonary disease and an emergency contraceptive, which contribute to stable revenue streams and allow for continued growth in its operations.

InPhase Technologies is a storage company focused on holographic data storage technology.

Beenos Partners is a Tokyo-based venture capital firm founded in 1999, originally established as NetPrice.com, an eCommerce service provider. The company transitioned from its initial focus to a broader role in the startup ecosystem, offering incubation and support through its in-house team of experienced entrepreneurs and specialists. Beenos Partners aims to assist startups in various sectors, including information technology, online marketplaces, online payment, inbound tourism, entertainment, manufacturing, mobile, and enterprise software. The firm leverages its expertise in engineering, design, data science, and business management to help entrepreneurs develop and expand their businesses in a rapidly evolving market.

Magically, Inc. specializes in communication and collaboration technologies aimed at enhancing personal and team interactions in a mobile workforce. The company offers a range of products, including MagicalDesk, an award-winning suite of information management tools tailored for corporate and SME users, and Magical WorkSpace, an enterprise application that facilitates workflow and team collaboration. Additionally, Magically provides SmartSpace, a suite of personal information management applications, and Magical SyncServer, which allows mobile users to manage and access their information across various devices. With a focus on accessibility across multiple platforms and languages, Magically's solutions cater to the needs of virtual communities. Founded in 1998, the company is headquartered in Redwood City, California, and maintains offices in Hong Kong, São Paulo, London, San Francisco, and Tokyo.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.